📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial. (2024)

First Author: Brown RB

Attributed to: Understanding novel disease processes underlying cerebral small vessel disease and determining whether they can be therapeutically modified funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/alz.13830

PubMed Identifier: 38629936

Publication URI: http://europepmc.org/abstract/MED/38629936

Type: Journal Article/Review

Volume: 20

Parent Publication: Alzheimer's & dementia : the journal of the Alzheimer's Association

Issue: 6

ISSN: 1552-5260